Tugal-Tutkun, I. Et Al. 2017. Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study. OCULAR IMMUNOLOGY AND INFLAMMATION , vol.25, no.1 , 62-70.

Tugal-Tutkun, I., KADAYIFÇILAR, S., Khairallah, M., Lee, S. C., Ozdal, P., Ozyazgan, Y., ... Song, J. H.(2017). Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study. OCULAR IMMUNOLOGY AND INFLAMMATION , vol.25, no.1, 62-70.

Tugal-Tutkun, Nuriye Et Al. "Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study," OCULAR IMMUNOLOGY AND INFLAMMATION , vol.25, no.1, 62-70, 2017

Tugal-Tutkun, Nuriye İ. Et Al. "Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study." OCULAR IMMUNOLOGY AND INFLAMMATION , vol.25, no.1, pp.62-70, 2017

Tugal-Tutkun, I. Et Al. (2017) . "Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study." OCULAR IMMUNOLOGY AND INFLAMMATION , vol.25, no.1, pp.62-70.

@article{article, author={Nuriye İlknur TUTKUN Et Al. }, title={Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study}, journal={OCULAR IMMUNOLOGY AND INFLAMMATION}, year=2017, pages={62-70} }